Summary of Classification and Labelling
Notified classification and labelling
General Information
610-527-3 |
(8R,9S,10R,13S,14S,17R)-17-ethynyl-10,13-dimethyl-1,2,4,7,8,9,10,11,12,13,14,15,16,17,-tetradecahydrospiro[cyclopenta[a]phenanthrene-3,2´-[1,3]dioxolan]-17-ol |
50407-76-6 |
Notified classification and labelling according to CLP criteria
STOT RE 2 |
H373
(not specified)
(oral)
|
H373
|
|
GHS08 GHS09 Wng
|
|
|
|
|
1 |
|
View details
|
Aquatic Acute 1 |
H400
|
H400
|
Aquatic Chronic 1 |
H410
|
H410
|
Number of Aggregated Notifications: 1